Consumption of seafood, serum liver enzymes, and blood levels of PFOS and PFOA in the Japanese population

Journal of Occupational Health

Volumn 55, Issue 3, 2013, Pages 184-194

  Yamaguchi, Miwa ^a   Arisawa, Kokichi ^a   Uemura, Hirokazu ^a   Katsuura Kamano, Sakurako ^a   Takami, Hidenobu ^a   Sawachika, Fusakazu ^a   Nakamoto, Mariko ^a   Juta, Tomoya ^a   Toda, Eisaku ^b   Mori, Kei ^b   Hasegawa, Manabu ^b   Tanto, Masaharu ^b   Shima, Masayuki ^c   Sumiyoshi, Yoshio ^c   Morinaga, Kenji ^c   Kodama, Kazunori ^c   Suzuki, Takaichiro ^c   Nagai, Masaki ^c   Satoh, Hiroshi ^c  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Japan Ministry of the Environment   (Japan)

^c The Study Group of the Accumulation of Dioxins in Humans   (Japan)

Author keywords

Blood; Fish intake; Perfluorooctanesulfonate (PFOS); Perfluorooctanoate (PFOA); Serum liver enzymes

Indexed keywords

EID: 84880311347     PISSN: 13419145     EISSN: 13489585     Source Type: Journal    
DOI: 10.1539/joh.12-0264-OA     Document Type: Article

References (40)

1. Butt CM, Berger Urs, Bossi R, Tomy Gregg T. Levels and trends of poly-and perfluorinated compounds in the arctic environment. Sci Total Environ 2010; 408: 2936-65.
2. Haug LS, Salihovic S, Jogsten IE, et al. Levels in food and beverages and daily intake of perfluorinated compounds in Norway. Chemosphere 2010; 80: 1137-43.
3. Olsen GW, Burris JM, Ehresman DJ, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retiered fluorochemical production workers. Environ Health Perspect 2007; 115: 1298-305.
4. Johansson N, Fredriksson A, Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 2008; 29: 160-9.
5. Cui L, Zhou Q, Liao C, Fu J, Jiang G. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis. Arch Environ Contam Toxicol 2009; 56: 338-49.
6. Genuis SJ, Birkholz D, Ralitsch M, Thibault N. Human detoxification of perfluorinated compounds. Public Health 2010; 124: 367-75.
7. Lindstrom AB, Strynar MJ, Libelo EL. Polyfluorinated compounds: past, present, and future. Environ Sci Technol 2011; 45: 7954-61.
8. Spliethoff HM, Tao L, Shaver SM, et al. Use of newborn screening program blood spots for exposure assessment: declining levels of perluorinated compounds in New York State infants. Environ Sci Technol 2008; 42: 5361-7.
9. Haug LS, Thomsen C, Brantsaeter AL, et al. Diet and particularly seafood are major sources of perfluorinated compounds in humans. Environ Int 2010; 36: 772-8.
10. Ericson I, Martí-Cid R, Nadal M, Van Bavel B, Lindström G, Domingo JL. Human exposure to perfluorinated chemicals through the diet: intake of perfluorinated compounds in foods from the Catalan (Spain) market. J Agric Food Chem 2008; 56: 1787-94.
11. Halldorsson TI, Fei C, Olsen J, Lipworth L, McLaughlin JK, Olsen SF. Dietary predictors of perfluorinated chemicals: a study from the Danish National Birth Cohort. Environ Sci Technol 2008; 42: 8971-7.
12. Uemura H, Arisawa K, Hiyoshi M, et al. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ Health Perspect 2009; 117: 568-73.
13. Arisawa K, Uemura H, Hiyoshi M, et al. Dietary patterns and blood levels of PCDDs, PCDFs, and dioxin-like PCBs in 1,656 Japanese individuals. Chemosphere 2011; 82: 656-62.
14. Hansen KJ, Clemen LA, Ellefson ME, Johnson HO. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol 2001; 35: 766-70.
15. SAS Institute. SAS/STAT Software: Changes and Enhancements through Release 6.12. SAS Institute, Cary 1997. 3.
16. Ehresman DJ, Froehlich JW, Olsen GW, Chang SC, Butenhoff JL. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res 2007; 103: 176-84.
17. Fromme H, Midasch O, Twardella D, Angerer J, Boehmer S, Liebl B. Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Int Arch Occup Environ Health 2007; 80: 313-9.
18. Toms LM, Calafat AM, Kato K, et al. Polyfluoroalkyl chemicals in pooled blood serum from infants, children and adults in Australia. Environ Sci Technol 2009; 43: 4194-9.
19. Harada K, Koizumi A, Saito N, et al. Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan. Chemosphere 2007; 66: 293-301.
20. Ingelido AM, Marra V, Abballe A, et al. Perfluorooctanesulfonate and perfluorooctanoic acid exposures of the Italian general population. Chemosphere 2010; 80: 1125-30.
21. Harada KH, Yang HR, Moon CS, et al. Levels of perfluorooctane sulfonate and perfluorooctanoic acid in female serum samples from Japan in 2008, Korea in 1994-2008 and Vietnam in 2007-2008. Chemosphere 2010; 79: 314-9.
22. Kim SK, Lee KT, Kang CS, et al. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environ Pollut 2011; 159: 169-74.
23. Olsen GW, Church TR, Miller JP, et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 2003; 111: 1892-901.
24. Olsen GW, Church TR, Larson EB, et al. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 2004; 54: 1599-611.
25. Eriksen KT, Sørensen M, McLaughlin JK, Tjønneland A, Overvad K, Raaschou-Nielsen O. Determinants of plasma PFOA and PFOS levels among 652 Danish men. Environ Sci Technol 2011; 45: 8137-43.
26. Harada K, Saito N, Inoue K, et al. The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years. J Occup Health 2004; 46: 141-7.
27. Monroy R, Morrison K, Teo K, et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 2008; 108: 56-62.
28. Harada K, Inoue K, Morikawa A, Yoshinaga T, Saito N, Koizumi A. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 2005; 99: 253-61.
29. Kärrman A, Ericson I, van Bavel B, et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 2007; 115: 226-30.
30. Amiano P, Dorronsoro M, de Renobales M, Ruiz de Gordoa JC, Irigoien I, EPIC Group of Spain. Very-long-chain omega-3 fatty acids as markers for habitual fish intake in a population consuming mainly lean fish: the EPIC cohort of Gipuzkoa. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 2001; 55: 827-32.
31. Rylander C, Sandanger TM, Frøyland L, Lund E. Dietary patterns and plasma concentrations of perfluorinated compounds in 315 Norwegian women: the NOWAC Postgenome Study. Environ Sci Technol 2010; 44: 5225-32.
32. Olsen GW, Zobel LR. Assessment of lipid, hepatic, and thyroid parameters with serum perfluoroocatanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 2007; 81: 231-46.
33. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluoroactanoate. J Occup Environ Med 2007; 49: 872-9.
34. Olsen GW, Burris JM, Burlew MM, Mandel JH. Epidemiologic assessment of worker serum perfluoroocatanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 2003; 45: 260-70.
35. Costa G, Sartori S, Consonni D. Thity years of medical surveillance in perfluooctanoic acid production workers. J Occup Environ Med 2009; 51: 364-72.
36. Lin CY, Lin LY, Chiang CK, et al. Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults. Am J Gastroenterol 2010; 105: 1354-63.
37. Gallo V, Leonardi G, Genser B, et al. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomark ers in a population with elevated PFOA exposure. Environ Health Perspect 2012; 120: 655-60.
38. Saito N, Harada K, Inoue K, Sasaki K, Yoshinaga T, Koizumi A. Perfluorooctanoate and perfluorooctane sulfonate concentrations in surface water in Japan. J Occup Health 2004; 46: 49-59.
39. Xie S, Wang T, Liu S, et al. Industrial source identification and emission estimation of perfluorooctane sulfonate in China. Environ Int 2013; 52: 1-8.
40. Willett WC. Nutritional Epidemiology, second edition. New York (United States): Oxford University Press; 1998. p.101-47.